Compare CStone Pharmaceuticals Co. Ltd. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
HKD 7,778 Million ()
NA (Loss Making)
NA
0.00%
-0.84
-112.58%
22.54
Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2018)
Net Profit:
-176 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
78.01%
0%
78.01%
6 Months
160.35%
0%
160.35%
1 Year
405.13%
0%
405.13%
2 Years
124.71%
0%
124.71%
3 Years
6.49%
0%
6.49%
4 Years
-58.9%
0%
-58.9%
5 Years
-38.76%
0%
-38.76%
CStone Pharmaceuticals Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
194.13%
EBIT Growth (5y)
12.64%
EBIT to Interest (avg)
-359.62
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.89
Sales to Capital Employed (avg)
0.47
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
40.04
EV to EBIT
-33.69
EV to EBITDA
-38.66
EV to Capital Employed
240.18
EV to Sales
61.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-713.01%
ROE (Latest)
-113.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
441.50
512.50
-13.85%
Operating Profit (PBDIT) excl Other Income
-49.40
-604.90
91.83%
Interest
16.40
13.10
25.19%
Exceptional Items
-4.70
0.30
-1,666.67%
Consolidate Net Profit
-98.90
-405.80
75.63%
Operating Profit Margin (Excl OI)
-234.20%
-1,305.50%
107.13%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -13.85% vs -8.45% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 75.63% vs 61.34% in Dec 2023
About CStone Pharmaceuticals Co. Ltd. 
CStone Pharmaceuticals Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






